Before the Dry Ice: Seven MTA Checks for UK Labs Sending Plasmids

In a UK lab, the request usually arrives as a friendly email. Can you send pX to a collaborator? You find the tube, check the freezer map, print a label and start thinking about dry ice. The Material Transfer Agreement, or MTA, is somewhere in the background, often forwarded as a PDF with a subject line that says legal review.

That is the problem. The MTA is not a courier form. It is the document that decides what the recipient can do with your plasmid, strain or cell line, who owns anything made from it, and whether the whole thing can quietly become a commercial product. Students and early-career scientists are often asked to arrange the shipment but rarely taught what the contract controls. So here is a practical pre-shipment check for UK labs, written for the person who actually has to find the tube.

The MTA is a permission slip, not a packaging note

Shipping paperwork tells the courier what is in the box. An MTA tells the recipient institution what it may do with the material. Those are different jobs. Before you book anything, confirm that the MTA has been executed by authorised signatories at both institutions. A principal investigator saying yes by email is not the same as a contracts office signing the agreement.

Check that the material named in the MTA matches what you plan to send. A plasmid ID, host strain, cell line name and any biosafety level should line up. If the agreement covers a plasmid but you are also sending a transformed strain, or a derivative made in your lab, say so. UK university contracts teams generally prefer a clean match at the start to a hurried amendment after the parcel has landed.

Derivative ownership is the clause everyone skips

For plasmids and strains, the most important word is often derivative. Many MTAs distinguish between the original material, unmodified progeny and modified material made by the recipient. If your collaborator will make a mutant, swap a promoter or move the insert into another host, the agreement should make clear who controls that derivative and whether it can be shared onward.

This is not academic hair-splitting. It affects the next paper, the next collaboration and sometimes the next spinout. If your project plan includes making derivatives, flag it before shipment. Ask the contracts contact whether the recipient will own the derivative, whether the provider retains any rights, and whether the derivative can be sent to a third lab. If the wording is vague, get clarification in writing. Do not assume that a broad academic collaboration agreement covers every plasmid that crosses the lab door.

Publication language: look for the review clock

Some MTAs give the provider a period to review manuscripts before submission. A 30-day or 60-day review window is not unusual. That can be reasonable for checking confidential information or patent-sensitive material, but it can also become a delay point if the clock is vague or if it applies to every abstract, poster and thesis chapter.

Check whether the clause covers preprints. UK life-science groups increasingly use preprints, and an MTA written for journal submissions may not have caught up. Check whether the review period has a hard maximum. Check whether the provider can do more than comment. If the agreement is silent on preprints or conference abstracts, ask for a short written clarification. A useful question is simple: what is the maximum delay, and does it apply to preprints and student theses?

Commercial use hides in plain sight

Many academic MTAs are for research use only. That phrase can rule out fee-for-service work, industry-funded screening, diagnostic development or use by a spinout. If the recipient is a company, expect a different agreement or a licence. If the recipient is a university lab with a startup on the side, the line can get blurry.

Before shipping, ask whether the material will be used in any project with a commercial partner, in a spinout incubator or in a service lab. If the answer is yes, send the query to your institution's contracts or technology transfer team. They may need a separate commercial MTA, a licence or a simple exclusion. It is much easier to sort this before the plasmid is in a courier's van than after a company has built a screening programme around it.

The university-to-company handoff is where parcels stall

When a UK university sends to a company, two legal teams with different priorities have to agree. The university may want publication rights, liability wording and control over derivatives. The company may want confidentiality, ownership of results and a quick route to commercial use. Add in governing law, indemnity and signatory authority, and a two-day shipment can become a two-month email chain.

Common delay points include a mismatch between the legal entity and the lab address, missing signatory authority on the company side, redlines over liability, and confusion about whether the agreement covers one material or a whole collection. If the receiving lab is part of a larger group, check whether each institution needs to sign. Third-party sharing clauses matter here too: a recipient should not forward the plasmid to another lab without permission.

Seven checks before you book a courier

1. Match the MTA to the material: plasmid ID, host strain, cell line, lot and biosafety level.
2. Confirm both parties are the correct legal entities, not just department names.
3. Read the derivative and progeny wording, especially if new constructs will be made.
4. Scan the publication clause for preprints, theses, abstracts and any review period.
5. Circle commercial-use language, including spinouts, industry-funded work and fee-for-service labs.
6. Check third-party sharing and whether the recipient can pass the material onward.
7. Confirm the final signed version and keep it with the shipment record.

None of this replaces legal advice. It is a lab-process check, not a contract review. But it keeps you from being the person who shipped first and discovered the publication clause later.

When legal goes quiet

Do not send the parcel under protest and hope the paperwork catches up. Keep the tube in the freezer, keep the courier booking open and ask for a named contact, a reference number and a realistic date. A weekly status email is boring, but it works. If the delay is serious, ask whether a short letter agreement or a clarified clause can unblock the shipment.

The parcel itself is the easy part. The permission is the bit that needs checking. In UK labs, a little time with the MTA before the dry ice can save a lot of time after the invoice.